OTSKY Overview
Upcoming Projects (OTSKY)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (OTSKY)
-
Discussing the potential of Centanafadine, a medication currently in development by Otsuka that for the treatment of ADHD
Ticker: OTSKY
Executed On: Dec 13, 2023 at 02:15 PM EST -
A Second Opinion: Looking at the future use of Recor Medical and Medtronic's ultrasound renal denervation (RDN) systems for patients with resistant hypertension
Tickers: MDT, OTSKY, ReCor Medical
Executed On: Dec 08, 2023 at 03:00 PM EST -
Looking at the future use of Recor Medical and Medtronic's ultrasound renal denervation (RDN) systems for patients with resistant hypertension
Tickers: MDT, ReCor Medical, OTSKY
Executed On: Dec 07, 2023 at 09:00 AM EST -
Reviewing the potential of Otsuka/Recor Medicals Paradise ultrasound renal denervation (RDN) system for high blood pressure
Tickers: OTSKY, MDT, ReCor Medical
Executed On: Nov 09, 2023 at 09:00 AM EST -
Delving into the data on Otsuka & Lundbeck's recently approved Rexulti (brexpiprazole) for patients with Alzheimer's dementia.
Ticker: OTSKY
Executed On: May 16, 2023 at 04:30 PM EDT
Upcoming & Overdue Catalysts (OTSKY)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (OTSKY)
-
Otsuka (OTSKY) and Akebia (AKBA) Announce U.S Collaboration and License Agreement for Vadadustat in Treatment of Anemia in Patients with Chronic Kidney Disease
Tickers: AKBA, OTSKY
Announcement Date: Dec 13, 2016
